about
Acceleration of alpha-synuclein aggregation by homologous peptidesDequalinium-induced protofibril formation of alpha-synucleinalpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson diseaseImmunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brainNeurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the genePassive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body diseaseHuman alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases.Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.Protein disorder in the human diseasome: unfoldomics of human genetic diseases.Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathyAggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutationsReducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models.Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson diseaseDementia with Lewy bodies: neuropathology.Familial Lewy body diseases.Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis.Differential expression of alpha-synuclein in hippocampal neurons.Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's disease.Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseasesCalpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains.Dementia with lewy bodies: molecular pathogenesis and implications for classification.Morphometry of the human substantia nigra in ageing and Parkinson's disease.Molecular imaging in hereditary forms of parkinsonism.Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles.Pantothenate kinase-associated neurodegeneration is not a synucleinopathyAmyloidogenesis of natively unfolded proteins.Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease.Association of glucocerebrosidase mutations with dementia with lewy bodiesAnti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.Interaction between pathogenic proteins in neurodegenerative disorders.Brain banks as key part of biochemical and molecular studies on cerebral cortex involvement in Parkinson's disease.Lewy pathology and neurodegeneration in premotor Parkinson's disease.Parkinson's disease and parkinsonism: neuropathology.Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.Pathology of Neurodegenerative Diseases.
P2860
Q24293132-E7E29F55-D439-4909-8D2C-D47DF4CDDA99Q24298122-D5A5628F-0AD8-4EF2-B488-9A14E8182C55Q28264682-A2BBCE2F-0B82-48FE-AF46-81407EEBE354Q28478382-54169373-4893-44CF-A654-671156DC460FQ28587583-3754D3E7-8156-49AD-B38D-CC7801F32A40Q28740551-A613A8F7-E143-4078-ACC6-E3E3FD048FABQ30476254-0B27D156-BAE3-4E88-8998-45A171C5B815Q31030866-2073C8A0-4F64-469D-9FC9-073C1FEB2FC5Q33470625-3F81344A-DA96-4E77-95A2-5143F232D857Q33481211-DB95DE75-628B-4419-8791-43F3B6F0D20DQ33670282-7B5C58E2-CD74-4EF1-95CD-2EDF6AB5551AQ33836384-9F384191-1833-4D83-AD44-1FA70431B261Q33865366-E5639C63-42D3-4D1F-BF00-8E10D1F76EE5Q33997481-E8DE8BF9-D6DC-4F03-81BB-EA23BFBF3D7EQ34108513-0AECCB58-E53B-43D0-BC6E-8A0ACA06B6FBQ35029472-B585CA38-A56D-4921-B0FD-FE19EB1DA1DAQ35029476-FBB1CD0D-20C0-4BEF-A37E-FDECACEEF780Q35058315-F474C6AA-83B7-4729-B085-BB73F615A199Q35107062-EEE0EEAD-7E56-4176-BF12-27C136FEC88EQ35609611-9383196D-5C86-4C43-941C-C27C6918F727Q35748184-B3B51369-08B0-4C9B-889B-3947180A46A6Q35757239-32045952-C5A9-4DCA-9F27-8B80CF2D945AQ35827966-DB47F02C-136C-4DA7-A99B-C71193F30963Q35863395-8ED355EE-36BC-4635-873C-1F864E0CB420Q36727465-FD59DFD1-E9A2-4575-879B-33A018112749Q36771898-370651FC-7EBC-49C5-80B9-AA376077B128Q36982173-A7431636-0B20-4435-8FCE-B9FD84E37F31Q37016212-68C47D30-BED1-427A-A37B-272924EE4EBFQ37184755-4481B567-0D18-43CC-B62F-CA7500A07A79Q37257402-FE331C7C-18F8-4B9D-94D8-5B59084E1E6EQ37379711-42A18AFC-A8F2-4B06-B6F8-BC817C7FED75Q37586721-4AD6742F-82F2-438B-858C-E392A8E308DBQ37791469-ACE55170-E743-4FE4-88DA-D4BFAA009731Q37969262-465F08D5-5044-468F-8D6E-70FDB53FC6C7Q37982151-9086F3CF-B5F7-4427-BF2E-268F7D8174A4Q38003064-DC030431-4545-4687-A6D1-01CC8C6A0A34Q38036232-633702B9-4F73-4525-9B66-FEEC13E1CB29Q38039857-B6B066F6-54B0-431C-A78D-1BF146A2067BQ38667942-50BAC556-9B49-4802-AC7B-13AB4B0D01A2Q39071493-FB1BCAC3-B101-4F35-9D84-97903D757F39
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Alpha-synuclein and the Lewy body disorders.
@ast
Alpha-synuclein and the Lewy body disorders.
@en
Alpha-synuclein and the Lewy body disorders.
@nl
type
label
Alpha-synuclein and the Lewy body disorders.
@ast
Alpha-synuclein and the Lewy body disorders.
@en
Alpha-synuclein and the Lewy body disorders.
@nl
prefLabel
Alpha-synuclein and the Lewy body disorders.
@ast
Alpha-synuclein and the Lewy body disorders.
@en
Alpha-synuclein and the Lewy body disorders.
@nl
P1476
Alpha-synuclein and the Lewy body disorders.
@en
P304
P356
10.1097/00019052-200108000-00001
P577
2001-08-01T00:00:00Z